<?xml version="1.0" encoding="UTF-8"?>
<AssessmentQuestion xmlns="http://soap.sforce.com/2006/04/metadata">
    <assessmentQuestionVersion>
        <isActive>true</isActive>
        <name>Lanadelumab_Submission_DiseaseStateOverview_Q11</name>
        <optionSourceResponseValue>false</optionSourceResponseValue>
        <questionText>The dose of lanadelumab will not be escalated to more than 300mg every two weeks in cases of inadequate response or loss ofresponse. The dose of berotralstat will not be escalated to more than 150mg daily in cases of inadequate response or loss of response.</questionText>
        <status>Active</status>
        <versionNumber>2</versionNumber>
    </assessmentQuestionVersion>
    <dataType>Checkbox</dataType>
    <developerName>Lanadelumab_Submission_DiseaseStateOverview_Q11</developerName>
    <name>Lanadelumab_Submission_DiseaseStateOverview_Q11</name>
    <questionCategory>Demographic</questionCategory>
</AssessmentQuestion>
